2024-10-24 20:16:41
Kexing Biopharm Makes it into China's Top 20 Biopharmaceutical Enterprises (Blood Products, Vaccines and Insulin) for Two Consecutive Years
Corporate/ 2023-07-24
Kexing Biopharm Makes it into China'...

SHENZHEN,China,July 7,2023-- Kexing Biopharmaceutical (688136.SH) has accomplished the impressive feat of being recognized on June 27 as one...

280 Bio receives IND approval from the FDA for YL-17231
Health/ 2023-07-22
280 Bio receives IND approval from the F...

---The Company announces to initiate Phase 1 Clinical Trial with the KRAS inhibitor YL-17231 in US-- SHANGHAI and SOUTH SAN FRANCISCO,Calif....

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release